Source: Virtual Congress 2021 – Interstitial lung disease around the world



Rating:

Share or cite this content

Citations should be made in the following way:
P. Faverio (Monza, Italy), A. Fumagalli (Monza, Italy), S. Conti (Monza, Italy), F. Madotto (Monza, Italy), S. Busnelli (Monza, Italy), F. Bini (Garbagnate Milanese, Italy), S. Harari (Milano, Italy), M. Mondoni (Milano, Italy), T. Oggionni (Pavia, Italy), E. Barisione (Genova, Italy), P. Ceruti (Brescia, Italy), C. Papetti (Garbagnate Milanese, Italy), A. De Laurentis (Garbagnate Milanese, Italy), A. Caminati (Milano, Italy), A. Valentino (Milano, Italy), S. Centanni (Milano, Italy), D. Noè (Milano, Italy), M. Della Zoppa (Pavia, Italy), S. Crotti (Pavia, Italy), M. Grosso (Genova, Italy), S. Sukkar (Genova, Italy), D. Modina (Brescia, Italy), M. Andreoli (Brescia, Italy), R. Nicali (Novara, Italy), G. Suigo (Busto Arsizio, Italy), F. De Giacomi (Monza, Italy), L. Mantovani (Monza, Italy), A. Pesci (Monza, Italy), F. Luppi (Monza, Italy). Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study. 3754

Member's Comments

No comment yet.

Related content which might interest you: Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study Source: Breathe, 15 (2) 144; 10.1183/20734735.0016-2019 Year: 2019 Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016 Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013 Assessment of nutritional status in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry Source: Eur Respir J 2015; 46: 186-196 Year: 2015 Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Evaluation of treatment with Nintedanib in patients with idiopathic pulmonary fibrosis: a proteomical approach Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 The lived experience of idiopatic pulmonary fibrosis: A qualitative study Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences Year: 2016 Prognostic evaluation in Chinese patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Exploring barriers to Pirfenidone adherence in patients with idiopathic pulmonary fibrosis: a prospective study Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Determinants of exercise limitation in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 107s Year: 2005 Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Osteoporosis treatment effectiveness in patient with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Considerations of a warm autopsy program for patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Predictors of physical activity in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Best abstracts in physical activity and telemedicine Year: 2016 Prevalence of pulmonary arterial hypertension in idiopathic pulmonary fibrosis: a multicenter study Source: Eur Respir J 2007; 30: Suppl. 51, 119s Year: 2007